XML 37 R64.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information (Schedule of Segment Information) (Details) (USD $) In Millions, unless otherwise specified | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 27 Months Ended | 3 Months Ended | 9 Months Ended |  | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 Imprelis [Member] | Sep. 30, 2012 Imprelis [Member] | Sep. 30, 2013 Imprelis [Member] | Sep. 30, 2012 Imprelis [Member] | Sep. 30, 2013 Imprelis [Member] | Sep. 30, 2013 Agriculture [Member] | Sep. 30, 2012 Agriculture [Member] | Sep. 30, 2013 Agriculture [Member] | Sep. 30, 2012 Agriculture [Member] | Dec. 31, 2012 Agriculture [Member] | Sep. 30, 2013 Agriculture [Member] Imprelis [Member] | Sep. 30, 2012 Agriculture [Member] Imprelis [Member] | Sep. 30, 2013 Agriculture [Member] Imprelis [Member] | Sep. 30, 2012 Agriculture [Member] Imprelis [Member] | Sep. 30, 2013 Electronics and Communications [Member] | Sep. 30, 2012 Electronics and Communications [Member] | Sep. 30, 2013 Electronics and Communications [Member] | Sep. 30, 2012 Electronics and Communications [Member] | Sep. 30, 2013 Industrial Biosciences [Member] | Sep. 30, 2012 Industrial Biosciences [Member] | Sep. 30, 2013 Industrial Biosciences [Member] | Sep. 30, 2012 Industrial Biosciences [Member] | Sep. 30, 2013 Nutrition and Health [Member] | Sep. 30, 2012 Nutrition and Health [Member] | Sep. 30, 2013 Nutrition and Health [Member] | Sep. 30, 2012 Nutrition and Health [Member] | Sep. 30, 2013 Performance Chemicals [Member] | Sep. 30, 2012 Performance Chemicals [Member] | Sep. 30, 2013 Performance Chemicals [Member] | Sep. 30, 2012 Performance Chemicals [Member] | Sep. 30, 2013 Performance Chemicals [Member] Titanium Dioxide Antitrust Litigation [Member] | Sep. 30, 2013 Performance Chemicals [Member] Titanium Dioxide Antitrust Litigation [Member] | Sep. 30, 2013 Performance Materials [Member] | Sep. 30, 2012 Performance Materials [Member] | Sep. 30, 2013 Performance Materials [Member] | Sep. 30, 2012 Performance Materials [Member] | Sep. 30, 2013 Safety and Protection [Member] | Sep. 30, 2012 Safety and Protection [Member] | Sep. 30, 2013 Safety and Protection [Member] | Sep. 30, 2012 Safety and Protection [Member] | Sep. 30, 2013 Pharmaceuticals [Member] | Sep. 30, 2012 Pharmaceuticals [Member] | Sep. 30, 2013 Pharmaceuticals [Member] | Sep. 30, 2012 Pharmaceuticals [Member] | Sep. 30, 2013 Other [Member] | Sep. 30, 2012 Other [Member] | Sep. 30, 2013 Other [Member] | Sep. 30, 2012 Other [Member] | Sep. 30, 2012 INVISTA [Member] Other [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Agriculture [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Agriculture [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Electronics and Communications [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Electronics and Communications [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Industrial Biosciences [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Industrial Biosciences [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Nutrition and Health [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Nutrition and Health [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Performance Chemicals [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Performance Chemicals [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Performance Materials [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Performance Materials [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Safety and Protection [Member] | Sep. 30, 2012 Restructuring Program 2012 [Member] Safety and Protection [Member]
Segment sales | $ 7,813 | $ 7,480 | $ 28,232 | $ 27,797 |  |  |  |  |  | $ 1,633 |  | $ 1,423 |  | $ 9,933 | [1] | $ 8,891 |  |  |  |  |  |  | $ 638 | $ 607 |  | $ 1,907 | $ 2,079 |  | $ 305 | $ 292 |  | $ 898 | $ 880 |  | $ 868 | $ 876 |  | $ 2,601 | $ 2,569 |  | $ 1,720 |  | $ 1,732 |  | $ 5,087 |  | $ 5,600 |  |  |  | $ 1,663 | $ 1,614 |  | $ 4,892 | $ 4,913 |  | $ 985 | $ 934 |  | $ 2,909 | $ 2,861 |  | $ 0 | $ 0 | $ 0 | $ 0 | $ 1 | $ 2 | $ 5 | $ 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: Transfers | 78 | 90 | 245 | 310 |  |  |  |  |  | 3 |  | 0 |  | 10 | [1] | 4 |  |  |  |  |  |  | 3 | 4 |  | 12 | 13 |  | 3 | 3 |  | 10 | 8 |  | 0 | 0 |  | 0 | 0 |  | 46 |  | 56 |  | 153 |  | 202 |  |  |  | 22 | 24 |  | 57 | 74 |  | 1 | 3 |  | 3 | 9 |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales | 7,735 | 7,390 | 27,987 | 27,487 |  |  |  |  |  | 1,630 |  | 1,423 |  | 9,923 | [1] | 8,887 |  |  |  |  |  |  | 635 | 603 |  | 1,895 | 2,066 |  | 302 | 289 |  | 888 | 872 |  | 868 | 876 |  | 2,601 | 2,569 |  | 1,674 |  | 1,676 |  | 4,934 |  | 5,398 |  |  |  | 1,641 | 1,590 |  | 4,835 | 4,839 |  | 984 | 931 |  | 2,906 | 2,852 |  | 0 | 0 | 0 | 0 | 1 | 2 | 5 | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
PTOI | 741 | 461 | 4,759 | 4,845 |  |  |  |  |  | (102) | [2] | (198) | [2],[3] | 2,240 | [1],[2] | 1,772 | [2],[3] |  |  |  |  |  | 97 | (99) | [3],[4] | 241 | 181 | [3],[4],[5] | 45 | 37 | [3] | 129 | 118 | [3] | 81 | 64 | [3] | 218 | 248 | [3] | 182 | [6] | 410 | [3] | 697 | [6] | 1,575 | [3] |  |  | 374 | 230 | [3],[4] | 1,002 | 851 | [3],[4] | 171 | 92 | [3] | 481 | 432 | [3] | 5 | 10 | 27 | 53 | (112) | (85) | (276) | (385) | [7] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment net assets |  |  |  |  |  |  |  |  |  | 9,692 |  |  |  | 9,692 |  |  |  | 4,756 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase in net assets |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,936 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency |  |  |  |  | (65) | (125) | (180) | (440) | (930) |  |  |  |  |  |  |  |  |  | (65) | (125) | (180) | (440) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (72) | (72) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Insurance recoveries |  |  |  |  | 25 |  | 25 |  |  |  |  |  |  |  |  |  |  |  | 25 |  | 25 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain on sale of equity method investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 122 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Charge related to litigation settlement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (137) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring charge |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (93) | (93) | (3) | (3) | (7) | (7) | (3) | (3) | (13) | (13) | (3) | (3) | (9) | (9) | (55) | (55)
Asset Impairment Charges |  | $ (242) |  | $ (242) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (150) |  |  | $ (150) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (92) |  |  | $ (92) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[1] | As of September 30, 2013, Agriculture net assets were $9,692, an increase of $4,936 from $4,756 at December 31, 2012. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.
[2] | Included charges of $(65) and $(180), offset by $25 of insurance recoveries, during the three and nine months ended September 30, 2013, respectively, and charges of $(125) and $(440) during the three and nine months ended September 30, 2012, respectively, recorded in other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 9 for additional information.
[3] | Included a $(93) restructuring charge impacting the following segments: Agriculture - $(3), Electronics & Communications - $(7), Industrial Biosciences - $(3), Nutrition & Health - $(13), Performance Chemicals - $(3), Performance Materials - $(9), and Safety & Protection - $(55).
[4] | Included a $(242) impairment charge recorded in employee separation/asset related charges, net related to asset groupings, which impacted the segments as follows: Electronics & Communications - $(150) and Performance Materials - $(92). See Note 3 for additional information.
[5] | Included a $122 gain recorded in other income, net related to the sale of the company's interest in an equity method investment.
[6] | Included a $(72) charge related to the titanium dioxide antitrust litigation. See Note 9 for additional information.
[7] | Included a $(137) charge recorded in other operating charges related to the company's settlement of litigation with INVISTA.

X
- Definition Insurance recoveries for litigation. + References No definition available. + Details
Name: | dd_InsuranceRecoveriesforLitigation
Namespace Prefix: | dd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Segment Net Assets Increase Decrease + References No definition available. + Details
Name: | dd_SegmentNetAssetsIncreaseDecrease
Namespace Prefix: | dd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228 + Details
Name: | us-gaap_AssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net of assets and liabilities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09.6,7) -URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606914-122999 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05.4) -URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e604008-122996 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 05 -Paragraph 4 -Article 6 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 09 -Paragraph 19 -Article 6 + Details
Name: | us-gaap_AssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of gain (loss) on sale or disposal of an equity method investment. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 + Details
Name: | us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 + Details
Name: | us-gaap_LossContingencyLossInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 + Details
Name: | us-gaap_RestructuringAndRelatedCostIncurredCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Related Parties -URI http://asc.fasb.org/extlink&oid=16382449 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07.1(c)) -URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 07 -Paragraph b -Subparagraph 1 -Article 6 + Details
Name: | us-gaap_RevenueFromRelatedParties
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration